๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Continuous generation of colitogenic CD4+ T cells in persistent colitis

โœ Scribed by Takayuki Tomita; Takanori Kanai; Toshimitsu Fujii; Yasuhiro Nemoto; Ryuichi Okamoto; Kiichiro Tsuchiya; Teruji Totsuka; Naoya Sakamoto; Mamoru Watanabe

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
554 KB
Volume
38
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Persistent retention of colitogenic CD4+
Persistent retention of colitogenic CD4+ memory T cells causes inflammatory bowel diseases to become intractable
โœ Takanori Kanai; Yasuhiro Nemoto; Takayuki Tomita; Teruji Totsuka; Mamoru Watanab ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 613 KB

Despite the advent of an age when "malignant" leukemia is cured by bone marrow transplantation, "benign" inflammatory bowel diseases (IBDs) are still intractable lifelong diseases. Why is it that once an IBD develops it lasts a long time? We propose that, the same as in the response to vaccination,

Negative feedback regulation of colitoge
Negative feedback regulation of colitogenic CD4+ T cells by increased granulopoiesis
โœ Yasuhiro Nemoto; Takanori Kanai; Shuji Tohda; Teruji Totsuka; Ryuichi Okamoto; K ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 997 KB

Background: Chronic inflammatory diseases are characterized by massive infiltration of innate and acquired immune cells in inflammatory sites. However, it remains unclear how these cells cooperate in the development of disease. Although bone marrow (BM) is a primary site for hematopoiesis of immune

Colitogenic CD4+ effector-memory T cells
Colitogenic CD4+ effector-memory T cells actively recirculate in chronic colitic mice
โœ Takayuki Tomita; Takanori Kanai; Yasuhiro Nemoto; Toshimitsu Fujii; Kengo Nozaki ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 553 KB

Background: Although the clinical usefulness of leukocytapheresis for patients with inflammatory bowel disease (IBD) has been reported as a selective removal therapy targeting pathogenic immune cells in blood circulation, it remains unclear whether colitogenic CD4 ฯฉ T cells continuously recirculate